Skip to main content
. 2022 Oct 10;15:5801–5814. doi: 10.2147/JIR.S385491

Figure 2.

Figure 2

The correlation between ST6GAL1 mRNA expression and HCC patients’ prognosis in TCGA database. (A and B) The overall survival (n = 364, (A)) and relapse-free survival (n = 316, (B)) analysis between ST6GAL1 expression and HCC; (C) A nomogram that combines ST6GAL1 and other prognostic factors in HCC; (D) The calibration curve of the nomogram; (EH) The overall survival analysis of ST6GAL1 expression in HCC patients with viral hepatitis (n = 150, (E)), no-viral hepatitis (n = 167, (F)), alcohol consumption (n = 115, (G)), and no-alcohol consumption (n = 202, (H)).